Abstract
In this issue of Blood, Friedberg and colleagues present results of a clinical trial that suggests a new treatment option for frail Hodgkin lymphoma (HL) patients, age 60 years and older.
Cite
CITATION STYLE
APA
Straus, D. J. (2017, December 28). Initial Hodgkin treatment of the frail elderly. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-10-812966
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free